These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A) causes Lafora progressive myoclonus epilepsy. Ianzano L; Young EJ; Zhao XC; Chan EM; Rodriguez MT; Torrado MV; Scherer SW; Minassian BA Hum Mutat; 2004 Feb; 23(2):170-176. PubMed ID: 14722920 [TBL] [Abstract][Full Text] [Related]
26. Direct interaction between ER membrane-bound PTP1B and its plasma membrane-anchored targets. Anderie I; Schulz I; Schmid A Cell Signal; 2007 Mar; 19(3):582-92. PubMed ID: 17092689 [TBL] [Abstract][Full Text] [Related]
27. Relationship between glycogen accumulation and the laforin dual specificity phosphatase. Wang W; Parker GE; Skurat AV; Raben N; DePaoli-Roach AA; Roach PJ Biochem Biophys Res Commun; 2006 Nov; 350(3):588-92. PubMed ID: 17022935 [TBL] [Abstract][Full Text] [Related]
28. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Ganesh S; Agarwala KL; Ueda K; Akagi T; Shoda K; Usui T; Hashikawa T; Osada H; Delgado-Escueta AV; Yamakawa K Hum Mol Genet; 2000 Sep; 9(15):2251-61. PubMed ID: 11001928 [TBL] [Abstract][Full Text] [Related]
29. [Lafora disease. A new case of confirmation of diagnosis on molecular genetic studies]. Martínez-Bermejo A; López-Martín V; Serratosa JM; Gutiérrez-Molina M; Gómez-Garre P; Arcas J; Tendero A; Roche C; Pérez-Mies B Rev Neurol; 2002 Jan 16-31; 34(2):117-20. PubMed ID: 11988905 [TBL] [Abstract][Full Text] [Related]
30. Transcriptional profiling of a mouse model for Lafora disease reveals dysregulation of genes involved in the expression and modification of proteins. Ganesh S; Tsurutani N; Amano K; Mittal S; Uchikawa C; Delgado-Escueta AV; Yamakawa K Neurosci Lett; 2005 Oct; 387(2):62-7. PubMed ID: 16084644 [TBL] [Abstract][Full Text] [Related]
31. [Molecular genetics of epilepsy]. Yamakawa K Rinsho Shinkeigaku; 2004 Nov; 44(11):858-60. PubMed ID: 15651314 [TBL] [Abstract][Full Text] [Related]
32. Interaction of PTPB with the insulin receptor precursor during its biosynthesis in the endoplasmic reticulum. Issad T; Boute N; Boubekeur S; Lacasa D Biochimie; 2005 Jan; 87(1):111-6. PubMed ID: 15733745 [TBL] [Abstract][Full Text] [Related]
33. Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease. Puri R; Suzuki T; Yamakawa K; Ganesh S Hum Mol Genet; 2012 Jan; 21(1):175-84. PubMed ID: 21965301 [TBL] [Abstract][Full Text] [Related]
34. Alternative splicing modulates subcellular localization of laforin. Ganesh S; Suzuki T; Yamakawa K Biochem Biophys Res Commun; 2002 Mar; 291(5):1134-7. PubMed ID: 11883934 [TBL] [Abstract][Full Text] [Related]
38. Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice. Vernia S; Heredia M; Criado O; Rodriguez de Cordoba S; Garcia-Roves PM; Cansell C; Denis R; Luquet S; Foufelle F; Ferre P; Sanz P Hum Mol Genet; 2011 Jul; 20(13):2571-84. PubMed ID: 21493628 [TBL] [Abstract][Full Text] [Related]
39. Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase. Wang W; Roach PJ Biochem Biophys Res Commun; 2004 Dec; 325(3):726-30. PubMed ID: 15541350 [TBL] [Abstract][Full Text] [Related]